General Announcement::COMMUNICATION PERTAINING TO THE LAUNCH OF JUBI-R (REMDESIVIR) IN INDIA

Issuer & Securities

Issuer/ Manager
JUBILANT PHARMA LIMITED
Securities
JUBILANTP US$300M4.875%N211006 - XS1493722299 - 4X7B
JUBILANTP US$200M6%N240305 - XS1958658509 - KBSB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
03-Aug-2020 21:56:04
Status
New
Announcement Sub Title
COMMUNICATION PERTAINING TO THE LAUNCH OF JUBI-R (REMDESIVIR) IN INDIA
Announcement Reference
SG200803OTHRQ7C3
Submitted By (Co./ Ind. Name)
Shyam S. Bhartia
Designation
Chairman and Managing Director
Effective Date and Time of the event
03/08/2020 17:00:00
Description (Please provide a detailed description of the event in the box below)
Communication pertaining to the launch of JUBI-R (remdesivir) in India for the treatment of COVID-19

Attachments

JPL Disclosure - JUBI-R Launch- August 3 2020.pdf
Total size =224K